Found 16 matching trials
A Study To Find Out How Fesoterodine Works In Children Aged 6 To 17 Years With Bladder Overactivity Caused By A Neurological Condition
PHASE3The objective of the study is to find out if the medicine fesoterodine is a...
Location
Urological Associates of Southern Arizona
Fasting Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mg
PHASE1The objective of this study was to investigate the single-dose relative bio...
Location
PRACS Institute, Ltd.
Fed Study of Oxybutynin Chloride Extended-release Tablets 10 mg and Ditropan XL® Tablets 10 mg
PHASE1The objective of this study was to investigate the single-dose relative bio...
Location
Kendle International Inc.
Fasting Study of Oxybutynin Chloride Extended-Release Tablets 15 mg and Ditropan XL® Tablets 15 mg
PHASE1The objective of this study was to investigate the bioequivalence of Oxybut...
Location
PRACS Institute Ltd. - Cetero Research
Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition
PHASE4This study will evaluate the safety and effectiveness of an anticholinergic...
Location
Watson Investigational Site
Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and Over
PHASE2The purpose of this study is to explore the possible cognitive effects of d...
Location
Washington Neuropsychological Institute LLC Georgetown
Oxybutynin ER to Promote Early Continence Recovery After Robotic Prostatectomy: A Randomized Controlled Trial
NAThe goal of this double-blind, randomized, placebo-controlled study is to e...
Location
National Taiwan University Hospital
Extended-Release Oxybutynin for the Treatment of Neurogenic Detrusor Overactivity
PHASE4The purpose of this study is to evaluate the effects and tolerability (how ...
Location
Multiple Locations
InSite for Over Active Bladder
PHASE4The purposes of this study are:
1. To provide evidence from a randomized c...
Location
Multiple Locations
Food Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mg
PHASE1The objective of this study was to investigate the single-dose relative bio...
Location
PRACS Institute, Ltd.